The 9th CML-CAB is just around the corner!
On 20 November 2019, 11 expert patient advocates from all continents will meet in Basel / Switzerland for a CML-CAB with Novartis.
We are proud to announce that Susanna Schaffert, President of Novartis Oncology, has accepted our invitation to join this 4-hour CAB-meeting.
The CML community is happy to have key leaders like Ms. Schaffert join us to discuss the patient community’s needs regarding the company’s drug development roadmap, their approach to make sure every CML patient in need is able to access Novartis’ treatments and to speak about potential pathways to cure from CML.
We have again pulled together an interesting agenda, with an interactive session on “Moving towards a patient-centric cure for CM” and a “Q&A session on Access & Patient Engagement in R&D” worthy of particular mention.